
|Articles|December 30, 2011
Dr. Bruce Cree Discusses Multiple Sclerosis Therapy in a Case Management Setting
Advertisement
In this segment, Dr. Bruce Cree, Assistant Professor of Clinical Neurology, Department of Neurology, University of California San Francisco, discusses how he determines the most appropriate medications for his patients, and working with third-party payers.
Deciding which treatment is selected is based upon tolerability and patent preference. It is important to give patient's different treatment options available in managed care plans. Dr. Cree addresses the potential harm of using third-party preferred medications.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
2
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
3
Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship
4
Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD
5




